Efficacy and safety in retinal vein occlusion treated with at least three consecutive intravitreal dexamethasone implants

Journal of Ophthalmology

Volumn 2016, Issue , 2016, Pages

  Proença Pina, Julia ^a   Turki, Khalil ^b   Labreuche, Julien ^c   Duhamel, Alain ^c   Tran, Thi Ha Chau ^d  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Orleans la Source Hospital   (France)

^c UNIV LILLE   (France)

^d UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84962244786     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2016/6016491     Document Type: Article

References (27)

1. S. L. Rogers, R. L. McIntosh, L. Lim, et al., "Natural history of branch retinal vein occlusion: an evidence-based systematic review, " Ophthalmology, vol. 117, no. 6, pp. 1094. e5-1101. e5, 2010.
2. R. L. McIntosh, S. L. Rogers, L. Lim, et al., "Natural history of central retinal vein occlusion: an evidence-based systematic review, " Ophthalmology, vol. 117, no. 6, pp. 1113. e15-1123. e15, 2010.
3. H. Noma, H. Funatsu, M. Yamasaki, et al., "Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion, " Eye, vol. 22, no. 1, pp. 42-48, 2008.
4. L. P. Aiello, R. L. Avery, P. G. Arrigg, et al., "Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders, " The New England Journal of Medicine, vol. 331, no. 22, pp. 1480-1487, 1994.
5. J.-E. Chang-Lin, M. Attar, A. A. Acheampong, et al., "Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant, " Investigative Ophthalmology and Visual Science, vol. 52, no. 1, pp. 80-86, 2011.
6. C. Lowder, R. Belfort Jr., S. Lightman, et al., "Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis, " Archives of Ophthalmology, vol. 129, no. 5, pp. 545-553, 2011.
7. D. S. Boyer, Y. H. Yoon, R. Belfort Jr., et al., "Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema, " Ophthalmology, vol. 121, no. 10, pp. 1904-1914, 2014.
8. M. D. Medeiros, R. Navarro, J. Garcia-Arumi, C. Mateo, and B. Corcostegui, "Dexamethasone intravitreal implant for treatment of patientswith recalcitrantmacular edema resulting from Irvine-Gass syndrome, " Investigative Ophthalmology and Visual Science, vol. 54, no. 5, pp. 3320-3324, 2013.
9. M. Srour, G. Querques, N. Leveziel, et al., "Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa, " Graefes Archive for Clinical and Experimental Ophthalmology, vol. 251, no. 6, pp. 1501-1506, 2013.
10. J. A. Haller, F. Bandello, R. Belfort Jr., et al., "Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion, " Ophthalmology, vol. 117, no. 6, pp. 1134. e3-1146. e3, 2010.
11. L. Joshi, S. Yaganti, M. Gemenetzi, et al., "Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-needed, " British Journal of Ophthalmology, vol. 97, no. 8, pp. 1040-1044, 2013.
12. A. Bezatis, G. Spital, F. Hohn, et al., "Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up-the SOLO study, " Acta Ophthalmologica, vol. 91, no. 5, pp. e340-e347, 2013.
13. W. J. Mayer, A. Wolf, M. Kernt, et al., "Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion, " Eye, vol. 27, no. 7, pp. 816-822, 2013.
14. B. D. Kuppermann, M. S. Blumenkranz, J. A. Haller, et al., "Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema, " Archives of Ophthalmology, vol. 125, no. 3, pp. 309-317, 2007.
15. J. T. Holladay, "Proper method for calculating average visual acuity, " Journal of Refractive Surgery, vol. 13, no. 4, pp. 388-391, 1997.
16. K. Schulze-Bonsel, N. Feltgen, H. Burau, L. Hansen, and M. Bach, "Visual acuities hand motion and counting fingers can be quantified with the freiburg visual acuity test, " Investigative Ophthalmology & Visual Science, vol. 47, no. 3, pp. 1236-1240, 2006.
17. G. Coscas, A. Augustin, F. Bandello, et al., "Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion, " European Journal of Ophthalmology, vol. 24, no. 1, pp. 1-9, 2014.
18. J. A. Haller, F. Bandello, R. Belfort Jr., et al., "Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results, " Ophthalmology, vol. 118, no. 12, pp. 2453-2460, 2011.
19. L. Querques, G. Querques, R. Lattanzio, et al., "Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion, " Ophthalmologica, vol. 229, no. 1, pp. 21-25, 2013.
20. I. Tservakis, C. Koutsandrea, D. Papaconstantinou, T. Paraskevopoulos, and I. Georgalas, "Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors, " Current Drug Safety, vol. 10, no. 2, pp. 145-151, 2015.
21. M. Brunner, I. Haueter, and C. Valmaggia, "Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease, " Klinische Monatsblatter fur Augenheilkunde, vol. 230, no. 4, pp. 396-400, 2013.
22. G. Querques, R. Lattanzio, L. Querques, et al., "Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function, " Retina, vol. 34, no. 2, pp. 330-341, 2014.
23. W.-S. Yeh, J. A. Haller, P. Lanzetta, et al., "Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant, " Ophthalmology, vol. 119, no. 6, pp. 1190-1198, 2012.
24. E. Moisseiev, M. Goldstein, M. Waisbourd, A. Barak, and A. Loewenstein, "Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion, " Eye, vol. 27, no. 1, pp. 65-71, 2013.
25. E. R. James, "The etiology of steroid cataract, " Journal of Ocular Pharmacology and Therapeutics, vol. 23, no. 5, pp. 403-420, 2007.
26. L. M. Meyer and C.-L. Schonfeld, "Secondary glaucoma after intravitreal dexamethasone 0. 7 mg implant in patients with retinal vein occlusion: a one-year follow-up, " Journal of Ocular Pharmacology and Therapeutics, vol. 29, no. 6, pp. 560-565, 2013.
27. A. Capone Jr., M. A. Singer, D. G. Dodwell, et al., "Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (shasta study), " Retina, vol. 34, no. 2, pp. 342-351, 2014.